WallStreetZenWallStreetZen

NASDAQ: PROK
Prokidney Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PROK

Based on 4 analysts offering 12 month price targets for Prokidney Corp

Min Forecast
$1.00-61.09%
Avg Forecast
$6.25+143.19%
Max Forecast
$9.00+250.19%

Should I buy or sell PROK stock?

Based on 4 analysts offering ratings for Prokidney Corp.

Strong Buy
Strong Buy
3 analysts 75%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
1 analysts 25%
Strong Sell
0 analysts 0%
Although PROK's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates PROK as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their PROK stock forecasts and price targets.

PROK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-15Find Out Why
lockedlocked$00.00+00.00%2025-07-14Find Out Why
lockedlocked$00.00+00.00%2025-07-09Find Out Why
lockedlocked$00.00+00.00%2025-06-30

1 of 1

Forecast return on equity

Is PROK forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is PROK forecast to generate an efficient return on assets?

Company
-30.54%
Industry
91.4%
PROK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PROK earnings per share forecast

What is PROK's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.47
Avg 2 year Forecast
-$0.45
Avg 3 year Forecast
-$0.42

PROK revenue forecast

What is PROK's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$774.2k+4.06%
Avg 2 year Forecast
$0.0-100%
Avg 3 year Forecast
$0.0-100%

PROK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PROK$2.57$6.25+143.19%Strong Buy
GOSS$3.32$8.33+150.99%Strong Buy
OMER$11.03$27.50+149.32%Strong Buy
RAPT$28.28$54.13+91.39%Strong Buy
GYRE$7.90$17.00+115.19%Strong Buy
View Top Biotech Stocks

Prokidney Stock Forecast FAQ

Is Prokidney Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: PROK) stock is to Strong Buy PROK stock.

Out of 4 analysts, 3 (75%) are recommending PROK as a Strong Buy, 0 (0%) are recommending PROK as a Buy, 0 (0%) are recommending PROK as a Hold, 1 (25%) are recommending PROK as a Sell, and 0 (0%) are recommending PROK as a Strong Sell.

If you're new to stock investing, here's how to buy Prokidney stock.

What is PROK's earnings growth forecast for 2025-2027?

(NASDAQ: PROK) Prokidney's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 45.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.81%.

Prokidney's earnings in 2025 is -$71,033,000.On average, 8 Wall Street analysts forecast PROK's earnings for 2025 to be -$141,241,741, with the lowest PROK earnings forecast at -$147,408,846, and the highest PROK earnings forecast at -$129,509,200. On average, 8 Wall Street analysts forecast PROK's earnings for 2026 to be -$136,247,890, with the lowest PROK earnings forecast at -$158,028,299, and the highest PROK earnings forecast at -$116,874,156.

In 2027, PROK is forecast to generate -$126,741,524 in earnings, with the lowest earnings forecast at -$165,699,576 and the highest earnings forecast at -$107,397,873.

What is PROK's revenue growth forecast for 2025-2027?

(NASDAQ: PROK) Prokidney's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 102.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.69%.

Prokidney's revenue in 2025 is $744,000.On average, 8 Wall Street analysts forecast PROK's revenue for 2025 to be $232,899,960, with the lowest PROK revenue forecast at $196,938,218, and the highest PROK revenue forecast at $315,876,098. On average, 7 Wall Street analysts forecast PROK's revenue for 2026 to be $0, with the lowest PROK revenue forecast at $0, and the highest PROK revenue forecast at $0.

In 2027, PROK is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is PROK's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PROK) forecast ROA is -30.54%, which is lower than the forecast US Biotechnology industry average of 91.4%.

What is PROK's Price Target?

According to 4 Wall Street analysts that have issued a 1 year PROK price target, the average PROK price target is $6.25, with the highest PROK stock price forecast at $9.00 and the lowest PROK stock price forecast at $1.00.

On average, Wall Street analysts predict that Prokidney's share price could reach $6.25 by Jul 15, 2026. The average Prokidney stock price prediction forecasts a potential upside of 143.19% from the current PROK share price of $2.57.

What is PROK's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: PROK) Prokidney's current Earnings Per Share (EPS) is -$0.55. On average, analysts forecast that PROK's EPS will be -$0.47 for 2025, with the lowest EPS forecast at -$0.49, and the highest EPS forecast at -$0.43. On average, analysts forecast that PROK's EPS will be -$0.45 for 2026, with the lowest EPS forecast at -$0.53, and the highest EPS forecast at -$0.39. In 2027, PROK's EPS is forecast to hit -$0.42 (min: -$0.55, max: -$0.36).

What is PROK's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PROK) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.